Amicus Therapeutics Inc. News
Amicus Therapeutics Stock Rises; Sells Unit Stake in SPAC Deal
Amicus is selling a stake in its gene-therapy unit to ARYA Sciences Acquisition IV, a special purpose acquisition company sponsored by Perceptive Advisors.
HubSpot, Twitter, Sonos: Latest Upgrades and Downgrades
TheStreet's weekly guide to upgrades, downgrades and price-target changes includes Estee Lauder, Twitter and Uber.
Amicus Reports Disappointing Tests Results for Pompe Disease Drug
Amicus tanks as analysts downgrade it after the company reported disappointing test results for its Pompe disease drug.
Fear of Big Sellers: Cramer's 'Mad Money' Recap
Jim Cramer says investors need to consider the bear the motivation, and they need to consider the big sellers they'll have to outrun.
FedEx, Funko, Amicus Therapeutics: 'Mad Money' Lightning Round
Jim Cramer takes a look at FedEx, Funko, Amicus Therapeutics, Turning Point Brands, Sirius XM Radio, and more.
Breaking News
RH Stock Slumps After Cutting 2022 Sales Forecast As Consumer Demand Wanes
“With mortgage rates double last year’s levels ... our expectation is that demand will continue to slow throughout the year,” said CEO Gary Friedman
Should I Buy a House Now? (It's Personal and Complicated)
Mortgage rates are up and some markets have cooled down, but the reality is that the decision is very personal.
Crypto Crash Exposes Robinhood and Coinbase To Predators
A year can be a lifetime in the cryptocurrency world as major players are reeling from heavy losses.
Micron Earnings Preview: Will Critical Support Hold?
Micron is set to report earnings on Thursday after the close, but the stock sits on critical support. Will it hold or will it fold?